Nomad Foods beats Q2 expectations and launches €800M refinancing to extend maturities
NOMD sits 32% above its 52-week low of $8.99.
Summary
Nomad Foods pre-announced better-than-expected Q2 2026 results and launched an €800 million debt refinancing to push out maturities to 2033, strengthening its balance sheet amid a turnaround.
Key Events · Earnings and Guidance · NOMD
-
Q2 Results Beat Expectations
Preliminary Q2 figures showed an organic revenue decline of 2.5–3.5% and Adjusted EBITDA of €120–€126 million, both ahead of prior-quarter guidance, while gross margin improved year-on-year.
-
Full-Year Guidance Reaffirmed
The full-year outlook was reiterated: organic revenue down 2–5%, Adjusted EBITDA down 5–10%, and Adjusted Free Cash Flow conversion of 90%+. EPS guidance is under review due to the refinancing's impact on interest expense.
-
€800M Refinancing Launched
Nomad Foods Bondco Plc is offering €800 million in senior secured notes due 2033 to refinance the existing €800 million notes due 2028, extending maturities by five years.
-
RCF Upsized by €105M
Contingent on the refinancing, the revolving credit facility will increase to €280 million, adding liquidity headroom.
Analysis · NOMD · Manufacturing
Preliminary Q2 results came in ahead of the outlook communicated last quarter, with Adjusted EBITDA landing between €120 million and €126 million. At the same time, the company is launching an €800 million senior secured notes offering to refinance its 2028 notes, pushing maturities out to 2033 and upsizing its revolving credit facility by €105 million. While the refinancing may lift near-term interest expense, it eliminates refinancing risk and underscores lender confidence. In a rebuilding year, the combination of an operational beat and proactive balance sheet management sends a positive signal, even as full-year revenue and EBITDA are still guided to decline.
At the time of this filing, NOMD was trading at $11.84 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $8.99 to $18.33. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.